Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT01155583 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma

Interventions

DRUG: azacitidine
DRUG: lenalidomide
DRUG: dexamethasone
OTHER: DNA methylation analysis
OTHER: gene expression analysis
OTHER: bone marrow aspiration
OTHER: immunohistochemistry staining method
OTHER: reverse transcriptase-polymerase chain reaction
OTHER: flow cytometry

Sponsor

Case Comprehensive Cancer Center